You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Claudin18.2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

Recruiting
  • Gastric Cancer
  • Chimeric antigen receptor T cell preparation targeting Claudin18.2
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jul 11, 2023

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma Trial in Shenzhen (Claudin18.2 CAR-T cells)

Recruiting
  • Advanced Pancreatic Carcinoma
  • Advanced Gastric Carcinoma
  • Claudin18.2 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2023

Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • LB1908
  • (no location specified)
Sep 9, 2022

Solid Tumor Trial (Cell injection)

Not yet recruiting
  • Solid Tumor
  • Cell injection
  • (no location specified)
Mar 10, 2022

Pancreas Tumor, Stomach Tumor, Gastrointestinal Tumors Trial (EO-3021)

Not yet recruiting
  • Pancreas Neoplasm
  • +5 more
  • (no location specified)
Jul 31, 2023

Advanced Digestive System Tumor Trial in China (IMC001 injection)

Not yet recruiting
  • Advanced Digestive System Tumor
  • IMC001 injection
  • Beijing, Beijing, China
  • +6 more
Jul 12, 2023

Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • Claudin 18.2 CAR-T
  • (no location specified)
Jul 21, 2022

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

Recruiting
  • CAR T-Cell Therapy
  • HEC-016(0.5×10^6 CAR-T Cells)
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Luohu Hospital
Mar 3, 2022

Solid Tumors Trial in Hefei, Shanghai (LCAR-C18S cells)

Recruiting
  • Solid Tumors
  • LCAR-C18S cells
  • Hefei, Anhui, China
  • +2 more
Jun 17, 2022

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial (CT048 Autologous Injection (CT048))

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT048 Autologous Injection (CT048)
  • (no location specified)
May 24, 2022

Advanced Solid Tumors Trial in Tianjin (SKB315 for injection)

Recruiting
  • Advanced Solid Tumors
  • SKB315 for injection
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
May 10, 2022

Pancreatic Cancer, Gastric Cancer Trial (CPO102)

Not yet recruiting
  • Pancreatic Cancer
  • Gastric Cancer
  • (no location specified)
Sep 14, 2021

Solid Tumors Trial (SPX-101)

Not yet recruiting
  • Solid Tumors
  • SPX-101
  • (no location specified)
Feb 8, 2022

Advanced Solid Tumors Trial in Beijing (QLS31905)

Recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 3, 2022

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Advanced Solid Tumor Trial in Shanghai (RC118-ADC)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Mar 21, 2022

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Advanced Cancer Trial in Beijing, Shanghai, Hangzhou (TST001 injection)

Recruiting
  • Advanced Cancer
  • TST001 injection
  • Beijing, Beijing, China
  • +2 more
Apr 13, 2022

Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)

Recruiting
  • Solid Tumor
  • +2 more
  • AB011 Injection
  • Hefei, Anhui, China
  • +11 more
Feb 7, 2022